Argireline (Acetyl Hexapeptide-3/8) is a synthetic hexapeptide marketed as a topical "Botox alternative" for reducing facial wrinkles. It works by inhibiting the SNARE complex responsible for neuromuscular junction signaling, reducing the release of neurotransmitters that trigger muscle contraction. Unlike Botox, it is applied topically and does not require injection. Clinical studies show modest wrinkle reduction (up to 30% depth reduction at 30 days), making it one of the most commercially successful cosmetic peptides worldwide.
Category: Cosmetic / Anti-Wrinkle. Evidence rating: F (anecdotal/unsupported).
Clinical status: Commercially available as cosmetic ingredient. Not a pharmaceutical.
Argireline mimics the N-terminal end of SNAP-25, one of the three proteins forming the SNARE complex required for vesicle fusion and neurotransmitter (acetylcholine) release at the neuromuscular junction. By competing with native SNAP-25 for incorporation into the SNARE complex, argireline reduces…
Research base: 2 registered clinical trials and 7 indexed publications reference Argireline.
Safety considerations: Very well tolerated topically; No significant adverse effects reported in clinical studies; No systemic absorption concerns at cosmetic concentrations.
Reviewed by the PeptideAtlas Editorial Team. Last reviewed: 2026-07-05.
No. Argireline produces modest wrinkle reduction (10-30%) with topical application, while Botox completely paralyzes targeted muscles via injection. Argireline is best for mild expression lines and maintenance between Botox treatments. It cannot replace Botox for deep wrinkles.
Argireline (Acetyl Hexapeptide-3) is a synthetic cosmetic peptide that mimics the N-terminal end of SNAP-25, inhibiting neuromuscular junction activity to reduce the appearance of expression lines and wrinkles.
ARGIRELINE (ACETYL HEXAPEPTIDE-3) has been studied for: Wrinkle reduction, Expression line softening, Non-invasive Botox alternative, Skin smoothing. Cosmetic hexapeptide; Botox-like mechanism without injection. Widely used in anti-wrinkle serums.
Competes with SNAP-25 for position in the SNARE complex, reducing vesicle docking and acetylcholine release at the neuromuscular junction, thereby decreasing muscle contraction intensity.